GeneDx Holdings WGS Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$21.02M— | —— | -$175.77M+68.0% | -$548.98M-124% | ||
| $25.22M+14.9% | $21.95M-34.9% | $33.73M-43.1% | $59.31M+172% | ||
| $32.16M+252% | $9.14M+2,903% | -$326K-101% | $41.98M-80.9% | ||
| $36.37M+228% | -$28.5M+84.2% | -$180.15M+43.6% | -$319.16M-67.6% | ||
| $19.02M+246% | $5.49M+4.6% | $5.25M-26.6% | $7.16M-23.9% | ||
| -$61.52M-104% | -$30.13M+31.1% | -$43.73M+69.1% | -$141.33M-580% | ||
| —— | —— | —— | $0-100% | ||
| $48.03M+8.7% | $44.16M-76.4% | $187.15M-5.5% | $197.96M-60.0% | ||
| $19.79M— | —— | —— | -$263.17M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does GeneDx Holdings's cash flow data come from?
- Every line is extracted from GeneDx Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.